Suggestions
Audrey Guazzone
Global Market Entry & Growth Strategist I Go-To-Market I Business Development I Market Insights I Specialized in Health & Tech, Founder of LeanLia
Audrey Guazzone is a multilingual growth strategist with a rich background in the health and technology sectors, boasting over a decade of experience in various strategic roles.
Her expertise spans deep tech, medical devices, digital health, and artificial intelligence products, where she focuses on innovative solutions that drive proactive alerts, risk identification, and behavior change facilitation.
Specializing in the United States market, Audrey has spent more than 15 years cultivating relationships in major innovation ecosystems while managing French American collaboration programs.
She is the CEO & Founder of LeanLia, a company dedicated to aiding businesses in achieving product market fit, establishing a strong market presence, and reaching their business objectives.
Audrey's educational background includes studies at prestigious institutions like Harvard University, MBS School of Business, Salem State University, Texas Tech University, and Lycée Champollion, focusing on international business, management, and entrepreneurship.
With a professional presence in both New York and Europe, Audrey Guazzone has held key positions in renowned organizations such as Stern Tech, LeanLia, Business France, Komodo Health, Prognos Health, Quanttus, Cangrade, Retis, FACCNE, Entrepose Group, and ITC.
Her vast career experience encompasses roles ranging from Partner and VP Global Markets to Director of Customer Success, Product Marketing Manager, CEO, and various other leadership positions in international business development, investment, and industrial buying.
Audrey is committed to assisting high-potential industry disruptors in entering new markets, accomplishing growth, and establishing a strong foothold in the competitive business landscape.
Highlights
I’m grateful that, while working at Prognos Health & Komodo Health, I had exposure to AI analytics programs and SaaS products aimed at identifying patients at risk and reducing the burden of disease.
Today, at the HIMSS opening keynote session, I was very excited to hear about the role of AI in healthcare to drive meaningful progress globally. Not only that, but it was given by one of the most influential global healthcare leaders - Robert Garrett, CEO of Hackensack Meridian Health and Chair of the World Economic Forum’s Health and Healthcare Governor’s Community.
As you will see in the video, Robert referred to very exciting AI solutions from India, Spain, and the United States to explain the potential of AI to scale and improve global health.
He also mentioned some of the strategic AI initiatives that he and his team are implementing at Hackensack Meridian Health, which were also very insightful.
#digitalhealth #healtcare #himss2024 #AI #globalhealth
